Source link : https://www.newshealth.biz/health-news/late-dupilumab-responders-have-unique-molecular-profile/
AMSTERDAM — A proteomics study designed to determine why some patients with atopic dermatitis (AD) respond quickly to dupilumab, others respond more slowly, and the remainder do not respond at all demonstrated that molecular responses in these three groups are very different. A discovery that could lead to personalizing therapies, the data identified “distinct systemic […]
Author : News Health
Publish date : 2024-10-09 09:49:51
Copyright for syndicated content belongs to the linked Source.
Categories